Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)

NCT04397692 is registered in ClinicalTrials.gov with Beyond Air Inc. as lead sponsor.

NCT NCT04397692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)
Lead sponsor
Beyond Air Inc.
Phase
Not applicable
Overall status
Terminated
Start date
June 13, 2020
Completion date
September 30, 2020
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid-19, inhaled nitric oxide, nitric oxide, pneumonia, viral, respiratory disease, sars-cov 2